Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 106.80B | 102.50B | 106.85B | 149.00B | 88.74B | 45.75B |
Gross Profit | 40.56B | 41.93B | 48.04B | 88.81B | 41.87B | 9.53B |
EBITDA | 42.31B | 41.81B | 50.18B | 85.75B | 42.98B | 6.60B |
Net Income | 8.77B | 8.81B | 11.88B | 28.75B | 8.56B | -5.50B |
Balance Sheet | ||||||
Total Assets | 137.90B | 131.14B | 143.58B | 158.02B | 147.12B | 121.97B |
Cash, Cash Equivalents and Short-Term Investments | 24.85B | 23.45B | 38.87B | 45.45B | 33.28B | 18.62B |
Total Debt | 29.77B | 30.09B | 31.80B | 32.17B | 36.24B | 38.12B |
Total Liabilities | 92.03B | 88.76B | 95.08B | 104.03B | 108.10B | 88.08B |
Stockholders Equity | 45.82B | 42.34B | 48.49B | 53.99B | 39.01B | 33.87B |
Cash Flow | ||||||
Free Cash Flow | 7.41B | 7.93B | 14.13B | 26.38B | 20.78B | 1.91B |
Operating Cash Flow | 20.13B | 20.11B | 24.70B | 35.14B | 28.82B | 10.39B |
Investing Cash Flow | -5.38B | -3.53B | -12.41B | -15.86B | -16.21B | -12.09B |
Financing Cash Flow | -14.74B | -17.74B | -18.14B | -15.41B | -4.84B | 2.99B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $139.25B | 10.29 | 11.75% | 4.53% | -9.86% | -32.59% | |
76 Outperform | $210.61B | 14.08 | 7.40% | 3.98% | ― | ― | |
75 Outperform | $79.76B | 9.93 | 11.25% | 25.78% | -10.84% | -61.73% | |
73 Outperform | $64.89B | 8.09 | 18.28% | 5.76% | 3.96% | -1.69% | |
73 Outperform | $49.91B | 18.38 | 4.78% | 3.43% | -2.17% | -25.00% | |
65 Neutral | $80.57B | 186.20 | -1.87% | 6.14% | -7.70% | -113.83% | |
52 Neutral | C$2.91B | -1.09 | -3.26% | 6.12% | 5.32% | -43.41% |